(Q43479636)

23 November 2017

Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models (English)

1 reference

Venezuelan equine encephalitis

23 November 2017

1 reference

1 reference

1 reference

William D Pratt

1

1 reference

23 November 2017

Nancy L Davis

series ordinal

2

1 reference

23 November 2017

Robert E Johnston

series ordinal

3

1 reference

23 November 2017

Jonathan F Smith

series ordinal

4

1 reference

23 November 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

23 November 2017

1 reference

23 November 2017

21

1 reference

23 November 2017

25-26

1 reference

23 November 2017

3854-3862

1 reference

Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse

23 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900328-1

7 January 2021

Experimental infection of horses with enzootic and epizootic strains of Venezuelan equine encephalomyelitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900328-1

7 January 2021

Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900328-1

7 January 2021

Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900328-1

7 January 2021

In vitro synthesis of infectious venezuelan equine encephalitis virus RNA from a cDNA clone: analysis of a viable deletion mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900328-1

7 January 2021

The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900328-1

7 January 2021

Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900328-1

7 January 2021

Selection for accelerated penetration in cell culture coselects for attenuated mutants of Venezuelan equine encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900328-1

7 January 2021

Sindbis virus mutants selected for rapid growth in cell culture display attenuated virulence in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900328-1

7 January 2021

Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900328-1

7 January 2021

Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900328-1

7 January 2021

Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900328-1

7 January 2021

The attenuation of poliovirus neurovirulence

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900328-1

7 January 2021

Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900328-1

7 January 2021

Rapid and efficient site-specific mutagenesis without phenotypic selection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900328-1

7 January 2021

A plaque neutralization method for arboviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900328-1

7 January 2021

Virulent and attenuated mutant Venezuelan equine encephalitis virus show marked differences in replication in infection in murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900328-1

7 January 2021

Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900328-1

7 January 2021

Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900328-1

7 January 2021

Comparative neurovirulence and tissue tropism of wild-type and attenuated strains of Venezuelan equine encephalitis virus administered by aerosol in C3H/HeN and BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900328-1

7 January 2021

Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900328-1

7 January 2021

Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5' untranslated region

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900328-1

7 January 2021

Limited potential for mosquito transmission of genetically engineered, live-attenuated Venezuelan equine encephalitis virus vaccine candidates.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900328-1

7 January 2021

10.1016/S0264-410X(03)00328-1

Identifiers

DOI

1 reference

23 November 2017

1 reference